Janssen Emergency Use Authorization

An Emergency Use Authorization (EUA) for Janssen COVID-19 Vaccine was issued by the Food and Drug Administration (FDA) on 2/27/21.

An EUA allows access to critical medical products that may help during a public health emergency. An EUA is different from approval/licensure. 

The following criteria must be met for an EUA to be issued: 

  • The product will be used for a serious or life-threatening disease or condition.
  • Based on the totality of scientific evidence available, it is reasonable to believe the product may be effective. 
  • The known and potential benefits of the product outweigh the known and potential risks of the product. 

info Emergency Use Authorization of Janssen COVID-19 Vaccine



Page last reviewed: November 16, 2021